These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 21457443
1. Regional variations in the concentrations of ketone bodies in cirrhosis and hepatic encephalopathy: a study in patients with TIPSS. Dabos KJ, Haughton BA, Pyleris E, Redhead DN, Hayes PC, Salder IH, Plevris JN. Liver Int; 2011 May; 31(5):707-11. PubMed ID: 21457443 [Abstract] [Full Text] [Related]
2. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial. Chen L, Xiao T, Chen W, Long Q, Li R, Fang D, Wang R. Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025 [Abstract] [Full Text] [Related]
3. [Portosystemic shunt via the left branch of portal vein for the prevention of encephalopathy following transjugular intrahepatic portosystemic shunt]. Chu J, Sun X, Piao L, Chen Z, Huang H, Lu C, Xu J. Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):437-40. PubMed ID: 12502447 [Abstract] [Full Text] [Related]
4. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U. Hepatogastroenterology; 2003 Dec; 50(54):1753-5. PubMed ID: 14696397 [Abstract] [Full Text] [Related]
5. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326 [Abstract] [Full Text] [Related]
6. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Huber M, Rössle M, Siegerstetter V, Ochs A, Haag K, Kist M, Blum HE. Hepatogastroenterology; 2001 Nov; 48(38):541-4. PubMed ID: 11379349 [Abstract] [Full Text] [Related]
7. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. N Engl J Med; 1995 May 04; 332(18):1192-7. PubMed ID: 7700312 [Abstract] [Full Text] [Related]
8. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents. Ockenga J, Kroencke TJ, Schuetz T, Plauth M, Kasim E, Petersein J, Schmidt HH, Lochs H. Scand J Gastroenterol; 2004 Oct 04; 39(10):994-9. PubMed ID: 15513340 [Abstract] [Full Text] [Related]
9. A predominant increase of arterial beta-hydroxybutyrate concentration during partial hepatectomies in patients with impaired indocyanine green clearance test. Higashi S, Tabata N, Kondo KH, Kai M, Miyamoto K, Maeda Y, Setoguchi T. J Surg Res; 1999 Feb 04; 81(2):243-8. PubMed ID: 9927547 [Abstract] [Full Text] [Related]
10. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC. Gut; 2006 Nov 04; 55(11):1617-23. PubMed ID: 16571635 [Abstract] [Full Text] [Related]
11. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests. Baron A, Gulberg V, Sauter G, Waggershauser T, Reiser M, Gerbes AL. Hepatogastroenterology; 1998 Nov 04; 45(24):2315-21. PubMed ID: 9951915 [Abstract] [Full Text] [Related]
12. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt]. Wu X, Cao J, Wu X. Zhonghua Wai Ke Za Zhi; 1996 May 04; 34(5):303-6. PubMed ID: 9387710 [Abstract] [Full Text] [Related]
13. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Nolte W, Wiltfang J, Schindler C, Münke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G. Hepatology; 1998 Nov 04; 28(5):1215-25. PubMed ID: 9794904 [Abstract] [Full Text] [Related]
14. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC. Am J Gastroenterol; 2000 Jan 04; 95(1):199-203. PubMed ID: 10638583 [Abstract] [Full Text] [Related]
16. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, Berger E, Blum U, Gabelmann A, Hauenstein K. N Engl J Med; 1994 Jan 20; 330(3):165-71. PubMed ID: 8264738 [Abstract] [Full Text] [Related]
17. [Hepatic encephalopathy after TIPS--retrospective study]. Stefánková J, Fejfar T, Safka V, Hůlek P, Krajina A, Fendrichová M. Vnitr Lek; 2002 May 20; 48(5):390-5. PubMed ID: 12061205 [Abstract] [Full Text] [Related]
18. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopy; 2002 Sep 20; 34(9):690-7. PubMed ID: 12195325 [Abstract] [Full Text] [Related]
19. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension]. François E, García-Pagán JC, Bru C, Feu F, Gilabert R, Escorsell A, Bosch J, Rodés J. Gastroenterol Hepatol; 1997 Jan 20; 20(1):1-4. PubMed ID: 9072189 [Abstract] [Full Text] [Related]
20. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Kramer L, Bauer E, Gendo A, Funk G, Madl C, Pidlich J, Gangl A. Am J Gastroenterol; 2002 Jan 20; 97(1):162-6. PubMed ID: 11808942 [Abstract] [Full Text] [Related] Page: [Next] [New Search]